Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 339 followers
Latest posts
Last updated about 2 hours ago
Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’
about 2 hours ago
Boehringer Ingelheim has suspended a phase 1 trial of an investigational small...
‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensions
about 22 hours ago
You might assume Chinese biotechs are enduring sleepless nights worrying about whether...
Amgen abandoning $500M+ Crohn’s collab won't derail TScan’s strategy
1 day ago
Amgen is walking away from a Crohn’s disease collaboration with TScan Therapeutics...
Merck and Sarah Cannon team up to boost oncology trial efficiency
2 days ago
Oncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with...
Trump looks set to tap White House aide Heidi Overton as next FDA commissioner
2 days ago
After three months without a permanent leader in place, President Donald Trump...
A ‘renaissance for biomedicine’: human brain organoids model development for 5 years
2 days ago
Scientists’ ability to recapitulate the human brain in a dish has always...
Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein
2 days ago
Tolerance Bio has vaulted into the clinic by agreeing to pay NeoImmuneTech...
New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem
2 days ago
Addressing shifts in the global clinical development ecosystem and how academia and...
Developing a Global Clinical Trial Strategy for Emerging Biotechs
2 days ago
Discussing how small biotechs can accelerate clinical development with fit-for-purpose global clinical...
How Pharma Teams Evaluate Biotech Companies for Partnerships and Acquisitions
2 days ago
Addressing how interactions around partnerships or acquisitions differ from those of investment...
Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push
2 days ago
Merck & Co. and Moderna's personalized mRNA cancer vaccine has successfully lengthened...
Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss
3 days ago
Following a phase 3 knee osteoarthritis failure that its CEO acknowledged caused...